Medtronic, Inc. (MDT) Reports In-Line Q3 EPS of 84c; Reaffirms FY12 Sales Outlook

February 21, 2012 7:16 AM EST
Medtronic, Inc. (NYSE: MDT) reported Q3 EPS of $0.84, in-line with the analyst estimate of $0.84. Revenue for the quarter came in at $3.92 billion versus the consensus estimate of $3.99 billion.

Reaffirms its FY12 sales guidance, sees EPS of $3.44-$3.47.

For earnings history and earnings-related data on Medtronic, Inc. (MDT) click here.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Earnings, Guidance

Related Entities


Add Your Comment